SRI International
333 Ravenswood Avenue
Menlo Park
California
94025
United States
Tel: 866-451-5998
Fax: 650-859-2889
Website: http://www.sri.com/
Email: biosciences@sri.com
About SRI International
SRI International’s Biosciences Division carries out basic research, drug discovery and drug development, and provides contract services. SRI Biosciences has all of the resources necessary to take R&D from Idea to IND and Beyond™ —from initial discovery to human clinical trials—and specializes in cancer, immunology and inflammation, infectious disease, and neuroscience. SRI’s product pipeline has yielded marketed drugs, therapeutics currently in clinical trials, and additional programs in earlier stages. In its CRO business, SRI has helped government and other clients and partners advance well over 100 drugs into patient testing. SRI is also working to create the next generation of technologies in areas such as diagnostics, drug delivery, medical devices, and systems biology.
161 articles about SRI International
-
SRI International: Research Evaluating Effectiveness of Behavioral Counseling and Varenicline for Smoking Cessation Featured in the American Journal of Preventive Medicine
5/18/2010
-
SRI International Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research
5/13/2010
-
SRI International Researchers Present Promising New Therapeutic for the Treatment of Multiple Myeloma
5/11/2010
-
SRI International to Demonstrate Dexterous Telesurgical Robot at Block Party Event During National Robotics Week
4/9/2010
-
SRI International Awarded National Institutes of Health (NIH) Preclinical Services Contract
3/25/2010
-
Early Detection Of Parasitic Diseases Using A 3-In-1 'Dipstick' Test, SRI International Study
3/23/2010
-
SRI International Researchers to Present Work on Early Detection Tool for Neglected Tropical Diseases at 2010 American Chemical Society Meeting
3/22/2010
-
Biomedical Advanced Research and Development Authority (BARDA) Project for Radiation Exposure Research Awarded to SRI International
2/23/2010
-
SRI International Expands Neurosciences Research with New Neurodegenerative Diseases Research Program
2/18/2010
-
SRI International Receives National Institutes of Health (NIH) Grants to Develop Improved Tomographic Imaging Technology
12/10/2009
-
SRI International Awarded National Institute of Mental Health Contract for Evaluation of Brain Imaging Agents and Medications for Treatment of Mental Disorders
10/5/2009
-
FDA Approves Pralatrexate for Treatment of Peripheral T-Cell Lymphoma; Drug Discovered and Developed by SRI International, Memorial Sloan-Kettering Cancer Center, and Southern Research Institute
9/28/2009
-
XOMA (US) LLC to Develop Therapeutic Antibody for H1N1 and H5N1 Influenza Viruses Under $2.2 Million U.S. Government Program Managed by SRI International
9/24/2009
-
Steelbox Demonstrates Open Video Framework with SRI International and Telindus Surveillance Solutions
9/21/2009
-
SRI International: Nine International Research Teams Collaborate to Successfully Operate Multiple Biomedical Robots from Numerous Locations New Software Protocol Enables Interoperability Among Telesurgical Systems
9/18/2009
-
Research Teams Successfully Operate Multiple Biomedical Robots From Numerous Locations, SRI International Study
9/18/2009
-
SRI International's Research on Nicotine Use and Dependence Featured in the National Cancer Institute's Tobacco Control Monograph Series
9/11/2009
-
Twin Research Registry at SRI International Seeks Twin Pairs for Seasonal Flu Vaccine Study at Stanford University
8/4/2009
-
SRI International to Screen Drugs That Fight 2009 H1N1 Influenza A
5/13/2009
-
SRI International Research on Sleep and Wakefulness Featured in "Neurobiology Select" Series of the Journal Cell
5/7/2009